Several studies in the literature have shown the increased expression of MMP-9 in CRC when compared to clinical-pathological variables like stage III and IV, lymph node metastases, distant metastases, peritumoral inflammatory infiltrate and grades of cell differentiation II and III. The gene discussed is MMP9; the disease is metastatic malignant neoplasm in the lymph nodes.